Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GSK plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GSK
New York
2836
www.gsk.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GSK plc
Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks
- Oct 1st, 2026 8:09 am
GSK (LSE:GSK) The Latest Update Raises A Bigger Question
- Sep 30th, 2026 5:13 am
Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies
- Sep 30th, 2026 5:00 am
GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?
- Sep 29th, 2026 5:37 am
GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated
- Sep 29th, 2026 5:30 am
Merck, Daiichi Withdraw FDA Filing for Lung Cancer Therapy
- Sep 28th, 2026 9:23 am
Berenberg Turns Bullish on GSK as its $750 Million Deal Adds to Pipeline Momentum
- Sep 24th, 2026 5:08 pm
GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger?
- Sep 24th, 2026 4:41 pm
GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity
- Sep 24th, 2026 2:59 pm
$3.3 Million in New Philanthropic Commitments for Good Jobs Western North Carolina from The Rockefeller Foundation, John M. Belk Endowment, and NC GSK Foundation
- Sep 24th, 2026 5:00 am
GSK Bets on Long-Acting Biologics and AI to Reshape Respiratory Care
- Sep 23rd, 2026 4:02 pm
GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take Shape
- Sep 23rd, 2026 4:02 am
ALK appoints Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy
- Sep 21st, 2026 3:00 am
ViiV Healthcare Partners with Prevention Access Campaign (PAC) to Celebrate 10 Years of U=U and Look to The Future
- Sep 17th, 2026 6:00 am
GSK (LSE:GSK) Stock Looks Reasonable As Its 58% Run Continues
- Sep 17th, 2026 2:11 am
GSK (LSE:GSK) Agrees Multiple Myeloma T Cell Deal
- Sep 16th, 2026 7:12 pm
GSK Targets Oncology Growth With Lung, Prostate and Gynecologic Cancer Pipeline
- Sep 16th, 2026 5:02 am
GSK Inks $750M Deal to Add Experimental Blood Cancer Therapy
- Sep 15th, 2026 9:22 am
GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring
- Sep 15th, 2026 8:23 am
Scroll